Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
MOBX filed a Form 144 reporting the planned sale of Common Class A securities. The filing lists 28,896 founder shares dated 12/21/2023 and 89,250 restricted stock award shares dated 05/05/2025 described as Services Rendered.
Mobix Labs, Inc. filed an update on several corporate initiatives, including an expected Form S-1 to register the resale of approximately 3,300,000 common shares for Kips Bay Select LP and about 1,239,613 shares for five other stockholders. The company is actively negotiating a potential acquisition of Vision Aerial, Inc. under a non-binding letter of intent, with completion subject to due diligence, definitive agreements, approvals and financing. Mobix Labs also plans a July 2026 stockholder meeting to seek approvals for issuing shares to Kips, amending its charter to change Class B common stock issuance restrictions, increasing shares under its equity incentive plan, and authorizing additional shares or convertible securities for future fundraising and acquisitions. Management expects to pursue additional capital raises that may involve equity or convertible securities and could dilute existing holders. The company reports having recently settled two lawsuits and satisfied approximately $3.74 million of debt liabilities, which it believes reduces outstanding obligations and related uncertainty.
Mobix Labs, Inc. files a prospectus supplement to its Form S-1 registering up to 2,412,711 shares of Class A common stock. The supplement incorporates material disclosed in the Company’s Form 8-K and Form 10-Q.
Separately, the Company amended and expanded a senior secured convertible note with Leviston, increasing funded amount to $3,333 (aggregate principal reported as $4,000 inclusive of original issue discount); the original note was satisfied through conversion into 2,500,000 shares. Management reports cash of $2,563 and an accumulated deficit of $166,566 as of March 31, 2026 and states there is substantial doubt about the Company’s ability to continue as a going concern absent additional financing.
Mobix Labs, Inc. reported sharply lower revenue and continued losses for the quarter ended March 31, 2026 while warning of substantial doubt about its ability to continue as a going concern. Quarterly net revenue was $970, down from $2,511 a year earlier, with a net loss of $5,853 compared with $2,291 in the prior-year period.
For the first six months of fiscal 2026, net revenue totaled $2,845 and the net loss was $15,978. Cash stood at $2,563 against total debt of $6,438, and net cash used in operations reached $9,017. The company improved its capital structure from a small equity deficit to positive stockholders’ equity of $8,845 through public equity offerings, ATM sales and exchanges of debt and payables into shares, but these transactions were dilutive to existing holders.
Management states that ongoing operating losses, negative operating cash flows and limited liquidity mean additional debt or equity financing is required to meet obligations over the next twelve months. Subsequent events include a 1‑for‑10 reverse stock split, full conversion of a $4,000 senior secured convertible note into 2,500,000 shares, and a new $2,400 Series A 10% Convertible Preferred Stock financing with attached purchase warrant, further emphasizing reliance on capital markets.
Mobix Labs, Inc. amended its senior secured convertible note with Leviston Resources on May 13, 2026, increasing the principal from $3 million to $4 million in exchange for an additional cash advance of $833,333.
The company also entered an Investor Rights Agreement giving Leviston the right, but not the obligation, over seven months to buy up to an additional $4.0 million of similar secured convertible notes. Between May 12 and May 18, 2026, Leviston converted the entire $4 million of principal plus accrued interest into 2,500,000 shares of Class A Common Stock, fully satisfying the note and terminating related agreements.
The share issuances relied on the Section 3(a)(9) exemption under the Securities Act, and Leviston’s beneficial ownership of Class A Common Stock did not exceed 4.99% at any time.
Mobix Labs, Inc. notified the SEC it cannot timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 under Rule 12b-25 because of accounting department turnover and the need for additional time to finalize its financial statements and disclosure controls. The company provided preliminary results: loss from operations of approximately $6.1 million, net revenues of approximately $970 thousand, and a net loss of approximately $5.9 million for the quarter ended March 31, 2026. The company stated its financial statements will continue to reflect substantial doubt about its ability to continue as a going concern for the next twelve months and expects to file the Form 10-Q within the extension period.
Mobix Labs, Inc. is registering the resale of up to 2,500,000 shares of Class A Common Stock, representing shares issuable upon conversion of a $3,000,000 senior secured convertible promissory note held by Leviston Resources, LLC. The company will receive no proceeds from these resales and the registration covers shares that would equal approximately 23.94% of outstanding Class A Common Stock as of April 16, 2026. The prospectus warns that the resale or market perception of these sales could materially depress the trading price of the Class A Common Stock.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs, Inc. director Michael J. Long reported equity awards in the company’s Class A common stock. He received 14,805 shares on February 25, 2026 and an additional 5,000 shares on March 30, 2026, both recorded as grants or awards at a price of $0.00 per share.
After these transactions, Long directly owned 124,932 shares of Class A common stock. A footnote explains that an earlier grant of Restricted Stock Units was made on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership was adjusted for rounding following a 1-for-10 reverse stock split effective April 6, 2026.
Mobix Labs director Kurt Busch reported new equity awards in Mobix Labs, Inc. Class A Common Stock. He received 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026 as grant or award acquisitions at no stated purchase price.
After these awards, Busch directly owns 60,961 Class A shares. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030. Reported holdings reflect a 1-for-10 reverse stock split on April 6, 2026.